Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity

Docetaxel is an effective drug for the treatment of metastatic breast cancer. However, the exact mechanisms and/or markers associated with chemosensitivity or resistance to docetaxel remain unclear. We previously showed that the expression of prostate apoptosis response 4 (PAR4) inhibits the growth...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bessa Garcia, Simone Aparecida, Pavanelli, Ana Carolina, Melo, Natália Cruz E, Nagai, Maria Aparecida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360433/
https://www.ncbi.nlm.nih.gov/pubmed/28259909
http://dx.doi.org/10.3892/ijmm.2017.2900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360433/
https://www.ncbi.nlm.nih.gov/pubmed/28259909
http://dx.doi.org/10.3892/ijmm.2017.2900

Ejemplares similares